Genetic Repositories Australia (GRA) is a national genetic repository for DNA and cell lines derived from appropriately consented disease-specific and population-based studies. GRA has been supported by a $2 million National Health & Medical Research Council (NHMRC) Enabling Facility Grant and is based at Neuroscience Research Australia (NeuRA). The Chief Investigators on the NHMRC Enabling Grant 401184 are Prof Peter Schofield (Neuroscience Research Australia and University of New South Wales), Assoc Prof Juleen Cavanaugh (Australian National University), Dr Susan Forrest (Australian Genome Research Facility) and Prof John Hopper (University of Melbourne). Change of funding arrangements for NHMRC Enabling Facilities Important changes in NHMRC Support Mechanisms have been implemented; please refer to the following letter for further information. NHMRC Support Mechanisms PDF Obtaining cost estimates for NHMRC Project Grant submissions If you are intending to submit a Project Grant application which involves the use of Genetic Repositories Australia, then please contact the facility via firstname.lastname@example.org or (02 9399 1725) as soon as possible to discuss your proposal and to obtain a cost estimate. Staff Kerrie Pierce
NeuRA has made a 3T MRI scanner available for research since 2003. The current scanner is a Philips 3T TX MRI (upgraded May 2010). The facility currently operates for research 50% of the time and is open for research to scientists on a merit-based, user pays basis. It supports an active MRI research community of researchers from UNSW, The University of Sydney, Macquarie University and The University of Western Sydney as well as researchers from interstate and international sites as required.
The objective of the Sydney Brain Bank, based at Neuroscience Research Australia, is to provide a research resource facility for the- collection characterisation storage distribution of human brain tissue for research purposes Our primary focus is on various neurodegenerative conditions, such as Alzheimer's and Parkinson's disease, and also unaffected people. Neurodegenerative disorders have a huge personal impact in addition to being an increasing economic burden to individuals and the community. There are currently no treatments for many of these disorders, and only symptomatic treatment for some. Researchers in Australia and overseas interested in investigating areas such as basic disease mechanisms, earlier and more accurate diagnosis, genetic contributions to diseases, better treatments, and ultimately, cure and prevention, can request this tissue for their research studies. To be successful in our goals, we rely on the generosity and altruism of people who donate their brains for research and also the scientists who request the tissue seeking to alleviate the suffering that neurodegenerative diseases cause. Staff Members Dr Claire Shepherd Professor Glenda Halliday Dr Andrew McGeachie Heather McCann Andrew Affleck Carla Scicluna Francine Carew-Jones